{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:28:49Z","timestamp":1793298529601,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejpn.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T14:21:01Z","timestamp":1553178061000},"page":"347-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Quality of life of patients with spinal muscular atrophy: A systematic review"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-7151","authenticated-orcid":false,"given":"Erik","family":"Landfeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Edstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sejersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1r","family":"Tulinius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejpn.2019.03.004_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0037-1603517","article-title":"Diagnosis and new treatment avenues in spinal muscular atrophy","volume":"48","author":"Pechmann","year":"2017","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.ejpn.2019.03.004_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00415-017-8549-1","article-title":"A multi-source approach to determine SMA incidence and research ready population","volume":"264","author":"Verhaart","year":"2017","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.ejpn.2019.03.004_bib3","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1007\/s11136-018-1945-x","article-title":"Measuring quality of life in children with spinal muscular atrophy: a systematic literature review","volume":"27","author":"Vaidya","year":"2018","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.ejpn.2019.03.004_bib4","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.ejpn.2019.03.004_bib5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/104990910201900109","article-title":"Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease","volume":"19","author":"Abresch","year":"2002","journal-title":"Am J Hosp Palliat Care"},{"issue":"5","key":"10.1016\/j.ejpn.2019.03.004_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mus.25148","article-title":"Correlates of health related quality of life in adult patients with spinal muscular atrophy","volume":"54","author":"Kruitwagen-Van Reenen","year":"2016","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ejpn.2019.03.004_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-016-0424-0","article-title":"Disease burden of spinal muscular atrophy in Germany","volume":"11","author":"Klug","year":"2016","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ejpn.2019.03.004_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pediatrneurol.2014.01.037","article-title":"Health-related quality of life in children and adolescents with spinal muscular atrophy in the Czech republic","volume":"50","author":"Kocova","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"12","key":"10.1016\/j.ejpn.2019.03.004_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.nmd.2009.09.009","article-title":"The PedsQL (TM) in pediatric patients with spinal muscular atrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory (TM) Generic Core Scales and Neuromuscular Module","volume":"19","author":"Iannaccone","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"18","key":"10.1016\/j.ejpn.2019.03.004_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","article-title":"Prospective cohort study of spinal muscular atrophy types 2 and 3","volume":"79","author":"Kaufmann","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ejpn.2019.03.004_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JND-140004","article-title":"A randomized, controlled clinical trial of exercise in patients with spinal muscular atrophy: methods and baseline characteristics","volume":"1","author":"Montes","year":"2014","journal-title":"J Neuromuscul Dis"},{"issue":"8","key":"10.1016\/j.ejpn.2019.03.004_bib12","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archneur.60.8.1130","article-title":"Reliability of 4 outcome measures in pediatric spinal muscular atrophy","volume":"60","author":"Iannaccone","year":"2003","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2019.03.004_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpn.2010.07.003","article-title":"Self-reported quality of life has no correlation with functional status in children and adolescents with spinal muscular atrophy","volume":"15","author":"De Oliveira","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"issue":"8","key":"10.1016\/j.ejpn.2019.03.004_bib14","doi-asserted-by":"crossref","first-page":"e12140","DOI":"10.1371\/journal.pone.0012140","article-title":"SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy","volume":"5","author":"Swoboda","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejpn.2019.03.004_bib15","doi-asserted-by":"crossref","first-page":"e21296","DOI":"10.1371\/journal.pone.0021296","article-title":"SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy","volume":"6","author":"Kissel","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejpn.2019.03.004_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-017-0695-0","article-title":"Social\/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain","volume":"12","author":"L\u00f3pez-Bastida","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.ejpn.2019.03.004_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002060-200302000-00009","article-title":"Spinal muscular atrophy type 1 quality of life","volume":"82","author":"Bach","year":"2003","journal-title":"Am J Phys Med Rehab"},{"issue":"7","key":"10.1016\/j.ejpn.2019.03.004_bib18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S1474-4422(17)30085-6","article-title":"Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Bertini","year":"2017","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.ejpn.2019.03.004_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (ISIS-SMN Rx) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ejpn.2019.03.004_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.ejpn.2019.03.004_bib21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CND.0b013e3181c5053b","article-title":"The PedsQL\u2122 in pediatric patients with duchenne muscular dystrophy: feasibility, reliability, and validity of the pediatric quality of life inventory neuromuscular module and generic core scales","volume":"11","author":"Davis","year":"2010","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ejpn.2019.03.004_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26109","article-title":"Psychometric analysis of the pediatric quality of life inventory 3.0 neuromuscular module administered to patients with duchenne muscular dystrophy: a rasch analysis","author":"Landfeldt","year":"2018","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ejpn.2019.03.004_bib23","doi-asserted-by":"crossref","DOI":"10.2471\/BLT.12.115063","article-title":"No physical health without mental health: lessons unlearned?","volume":"91","author":"Kolappa","year":"2013","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.ejpn.2019.03.004_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/0272989X11401031","article-title":"Catalogue of EQ-5D scores for the United Kingdom","volume":"31","author":"Sullivan","year":"2011","journal-title":"Med Decis Making"},{"key":"10.1016\/j.ejpn.2019.03.004_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-1-54","article-title":"The Health Utilities Index (HUI): concepts, measurement properties and applications","volume":"1","author":"Horsman","year":"2003","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"10.1016\/j.ejpn.2019.03.004_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta5040","article-title":"Quality-of-life measures in chronic diseases of childhood","volume":"5","author":"Eiser","year":"2001","journal-title":"Health Technol Assess"},{"issue":"2","key":"10.1016\/j.ejpn.2019.03.004_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jpepsy\/21.2.175","article-title":"Assessment of health-related quality of life in children and adolescents: an integrative review","volume":"21","author":"Spieth","year":"1996","journal-title":"J Pediatr Psychol"},{"issue":"3","key":"10.1016\/j.ejpn.2019.03.004_bib28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/14737167.5.3.353","article-title":"KIDSCREEN-52 quality-of-life measure for children and adolescents","volume":"5","author":"Ravens-Sieberer","year":"2005","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"10.1016\/j.ejpn.2019.03.004_bib29","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/humu.22390","article-title":"The TREAT-NMD Duchenne muscular dystrophy registries: conception, design and utilisation by industry and academia","volume":"34","author":"Bladen","year":"2013","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.ejpn.2019.03.004_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13023-019-0998-4","article-title":"SMArtCARE \u2013 a platform to collect real-life outcome data of patients with spinal muscular atrophy","volume":"14","author":"Pechmann","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819300030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379819300030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:37:08Z","timestamp":1761071828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379819300030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1090379819300030"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.03.004","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life of patients with spinal muscular atrophy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}